{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:16:07Z","timestamp":1787008567809,"version":"build-2736575974"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":238,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diagnosis of the fatal neurodegenerative disease amyotrophic lateral sclerosis is challenging. Neurofilaments, indicative of neuronal damage, along with creatine kinase, creatinine, myoglobin, and troponin T, representing muscular damage, have been identified as promising fluid biomarkers. This study aims to comprehensively assess and compare their diagnostic and prognostic potential in a \u2018real-world\u2019 cohort of patients with amyotrophic lateral sclerosis. About 77 patients with amyotrophic lateral sclerosis and its clinical variants, and 26 age- and sex-matched controls with various neuromuscular and neurodegenerative diseases, were retrospectively included in this monocentric, cross-sectional study. Neurofilaments in cerebrospinal fluid and biomarkers of muscular damage in serum were measured and correlated with demographic features, motor function, survival time, clinical phenotypes, and the extent of upper and lower motor neuron involvement. Neurofilament, myoglobin, and troponin T concentrations were higher in patients with amyotrophic lateral sclerosis compared to disease controls. Higher neurofilament levels correlated with lower motor function and faster disease progression rate, while higher creatine kinase and creatinine concentrations were linked to preserved motor function. In contrast, troponin T elevation indicated poorer fine and gross motor functions. Increased neurofilament levels were associated with shorter survival, whereas biomarkers of muscular damage lacked survival correlation. Neurofilament concentrations were higher in classical amyotrophic lateral sclerosis than in progressive muscular atrophy, while myoglobin and troponin T levels were elevated in progressive muscular atrophy compared to primary lateral sclerosis. Neurofilaments were predominantly linked to upper motor neuron involvement. Our findings confirmed the robust diagnostic and prognostic value of neurofilaments in amyotrophic lateral sclerosis. Elevated neurofilament concentrations were associated with higher disease severity, faster disease progression, shorter survival, and predominant upper motor neuron degeneration. Biomarkers of muscular damage were inferior in distinguishing amyotrophic lateral sclerosis from other neuromuscular and neurodegenerative diseases. However, they may serve as complementary biomarkers and support in discriminating clinical variants of amyotrophic lateral sclerosis.<\/jats:p>","DOI":"10.1093\/braincomms\/fcae288","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T04:37:33Z","timestamp":1724647053000},"source":"Crossref","is-referenced-by-count":18,"title":["Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1453-1681","authenticated-orcid":false,"given":"Maximilian","family":"Vidovic","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 \u00a0","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna Sophie","family":"Lapp","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 \u00a0","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 \u00a0","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Plitzko","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 \u00a0","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-053X","authenticated-orcid":false,"given":"Michael","family":"Seifert","sequence":"additional","affiliation":[{"name":"Carl Gustav Carus Faculty of Medicine, Institute for Medical Informatics and Biometry (IMB), Technische Universit\u00e4t Dresden , Dresden 01307 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Steinacker","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin-Luther-University of Halle-Wittenberg , Halle (Saale) 06120 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Martin-Luther-University of Halle-Wittenberg , Halle (Saale) 06120 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-7791","authenticated-orcid":false,"given":"Andreas","family":"Hermann","sequence":"additional","affiliation":[{"name":"Translational Neurodegeneration Section \u2018Albrecht Kossel\u2019, Department of Neurology, University Medical Center Rostock, University of Rostock , Rostock 18147 ,","place":["Germany"]},{"name":"German Center for Neurodegenerative Diseases (DZNE), Site Rostock\/Greifswald , Rostock 18147 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , Dresden 01307 \u00a0","place":["Germany"]},{"name":"German Center for Neurodegenerative Diseases (DZNE) , Site Dresden, Dresden 01307 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"issue":"2","key":"2024103011294285500_fcae288-B1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"issue":"10360","key":"2024103011294285500_fcae288-B2","first-page":"1363","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet Rheumatol."},{"issue":"5","key":"2024103011294285500_fcae288-B3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"issue":"5","key":"2024103011294285500_fcae288-B4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cells12050736","article-title":"Current state and future directions in the diagnosis of amyotrophic lateral sclerosis","volume":"12","author":"Vidovic","year":"2023","journal-title":"Cells"},{"issue":"1","key":"2024103011294285500_fcae288-B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid biomarkers for amyotrophic lateral sclerosis: A review","volume":"19","author":"Irwin","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2024103011294285500_fcae288-B6","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"2024103011294285500_fcae288-B7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"2024103011294285500_fcae288-B8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De Schaepdryver","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2024103011294285500_fcae288-B9","first-page":"12","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: A prospective study on 455 patients","volume":"87","author":"Steinacker","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2024103011294285500_fcae288-B10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1152\/jn.00398.2021","article-title":"Phosphorylated neurofilament heavy chain: A potential diagnostic biomarker in amyotrophic lateral sclerosis","volume":"127","author":"Heckler","year":"2022","journal-title":"J Neurophysiol"},{"issue":"6","key":"2024103011294285500_fcae288-B11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/ene.15773","article-title":"Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis-a cross-sectional multicenter study","volume":"30","author":"Meyer","year":"2023","journal-title":"Eur J Neurol"},{"issue":"6","key":"2024103011294285500_fcae288-B12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mus.27818","article-title":"Neurofilament light-chain response during therapy with antisense oligonucleotide tofersen in SOD1 -related ALS\u202f: Treatment experience in clinical practice","volume":"67","author":"Meyer","year":"2023","journal-title":"Muscle Nerve."},{"issue":"2","key":"2024103011294285500_fcae288-B13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1\u20132 trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"2024103011294285500_fcae288-B14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"2024103011294285500_fcae288-B15","doi-asserted-by":"crossref","first-page":"102495","DOI":"10.1016\/j.eclinm.2024.102495","article-title":"Effects of tofersen treatment in patients with SOD1-ALS in a \u201creal-world\u201d setting\u2014A 12-month multicenter cohort study from the German early access program","volume":"69","author":"Wiesenfarth","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"11","key":"2024103011294285500_fcae288-B16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","article-title":"Tofersen: First approval","volume":"83","author":"Blair","year":"2023","journal-title":"Drugs"},{"issue":"12","key":"2024103011294285500_fcae288-B17","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1007\/s00415-019-09507-6","article-title":"Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis","volume":"266","author":"Ito","year":"2019","journal-title":"J Neurol"},{"issue":"10","key":"2024103011294285500_fcae288-B18","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1007\/s00415-022-11195-8","article-title":"Creatine kinase and prognosis in amyotrophic lateral sclerosis: A literature review and multi-centre cohort analysis","volume":"269","author":"Gao","year":"2022","journal-title":"J Neurol"},{"issue":"2","key":"2024103011294285500_fcae288-B19","doi-asserted-by":"crossref","first-page":"fcaa152","DOI":"10.1093\/braincomms\/fcaa152","article-title":"Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and Parkinson\u2019s disease","volume":"2","author":"Cui","year":"2020","journal-title":"Brain Commun"},{"issue":"5","key":"2024103011294285500_fcae288-B20","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/cells9051174","article-title":"Creatine kinase and progression rate in amyotrophic lateral sclerosis","volume":"9","author":"Ceccanti","year":"2020","journal-title":"Cells"},{"issue":"5","key":"2024103011294285500_fcae288-B21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/acn3.51340","article-title":"Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment","volume":"8","author":"Freigang","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2024103011294285500_fcae288-B22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fneur.2017.00322","article-title":"Correlation of creatine kinase levels with clinical features and survival in amyotrophic lateral sclerosis","volume":"8","author":"Tai","year":"2017","journal-title":"Front Neurol"},{"issue":"6","key":"2024103011294285500_fcae288-B23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/ene.12995","article-title":"Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis","volume":"23","author":"Rafiq","year":"2016","journal-title":"Eur J Neurol"},{"issue":"3\u20134","key":"2024103011294285500_fcae288-B24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/21678421.2019.1572192","article-title":"Plasma creatinine and amyotrophic lateral sclerosis prognosis: A systematic review and meta-analysis","volume":"20","author":"Lanznaster","year":"2019","journal-title":"Amyotroph Lateral Scler Front Degener"},{"issue":"20","key":"2024103011294285500_fcae288-B25","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1242\/jeb.01172","article-title":"Myoglobin: An essential hemoprotein in striated muscle","volume":"207","author":"Ordway","year":"2004","journal-title":"J Exp Biol"},{"issue":"12","key":"2024103011294285500_fcae288-B26","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1242\/jeb.00243","article-title":"Myoglobin function reassessed","volume":"206","author":"Wittenberg","year":"2003","journal-title":"J Exp Biol"},{"issue":"4","key":"2024103011294285500_fcae288-B27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13760-015-0596-8","article-title":"Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis","volume":"116","author":"Mach","year":"2016","journal-title":"Acta Neurol Belg"},{"issue":"22","key":"2024103011294285500_fcae288-B28","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2014.03.027","article-title":"Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: Implications for the diagnosis of myocardial infarction","volume":"63","author":"Rittoo","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2024103011294285500_fcae288-B29","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1038\/s41598-024-57185-w","article-title":"Troponin T is elevated in a relevant proportion of patients with 5q-associated spinal muscular atrophy","volume":"14","author":"Lapp","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"2024103011294285500_fcae288-B30","doi-asserted-by":"crossref","first-page":"fcab274","DOI":"10.1093\/braincomms\/fcab274","article-title":"Teaching an old dog new tricks: Serum troponin T as a biomarker in amyotrophic lateral sclerosis","volume":"3","author":"Castro-Gomez","year":"2021","journal-title":"Brain Commun"},{"issue":"8","key":"2024103011294285500_fcae288-B31","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","article-title":"A proposal for new diagnostic criteria for ALS","volume":"131","author":"Shefner","year":"2020","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"issue":"5","key":"2024103011294285500_fcae288-B32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1\u20132","key":"2024103011294285500_fcae288-B33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"issue":"2","key":"2024103011294285500_fcae288-B34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"key":"2024103011294285500_fcae288-B35","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988","edition":"2nd ed"},{"issue":"4857","key":"2024103011294285500_fcae288-B36","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"issue":"11","key":"2024103011294285500_fcae288-B37","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jalz.2019.07.009","article-title":"Comparison of variables associated with CSF neurofilament, total-tau, and neurogranin","volume":"15","author":"Mielke","year":"2019","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"issue":"3","key":"2024103011294285500_fcae288-B38","first-page":"69","article-title":"Statistics corner: A guide to appropriate use of correlation coefficient in medical research","volume":"24","author":"Mukaka","year":"2012","journal-title":"Malawi Med J J Med Assoc Malawi"},{"issue":"3","key":"2024103011294285500_fcae288-B39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward\u2019s hierarchical agglomerative clustering method: Which algorithms implement ward\u2019s criterion?","volume":"31","author":"Murtagh","year":"2014","journal-title":"J Classif"},{"issue":"5\u20136","key":"2024103011294285500_fcae288-B40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","article-title":"Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS","volume":"17","author":"Oeckl","year":"2016","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"2024103011294285500_fcae288-B41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","article-title":"Diagnostic and prognostic performance of neurofilaments in ALS","volume":"9","author":"Poesen","year":"2019","journal-title":"Front Neurol"},{"issue":"24","key":"2024103011294285500_fcae288-B42","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"2024103011294285500_fcae288-B43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","article-title":"CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis","volume":"265","author":"Rossi","year":"2018","journal-title":"J Neurol"},{"issue":"1","key":"2024103011294285500_fcae288-B44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mus.880080103","article-title":"Immunohistochemical study of myoglobin in neuromuscular diseases","volume":"8","author":"Kagawa","year":"1985","journal-title":"Muscle Nerve"},{"issue":"17","key":"2024103011294285500_fcae288-B45","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","article-title":"Diseased skeletal muscle: A noncardiac source of increased circulating concentrations of cardiac troponin T","volume":"58","author":"Jaffe","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2024103011294285500_fcae288-B46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/acn3.51299","article-title":"Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis","volume":"8","author":"Guo","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"14","key":"2024103011294285500_fcae288-B47","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2018.01.070","article-title":"Elevated cardiac troponin T in patients with skeletal myopathies","volume":"71","author":"Schmid","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2024103011294285500_fcae288-B48","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3390\/life13061301","article-title":"Serum neurofilaments in motor neuron disease and their utility in differentiating ALS, PMA and PLS","volume":"13","author":"McCluskey","year":"2023","journal-title":"Life"},{"issue":"4","key":"2024103011294285500_fcae288-B49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2019-322541","article-title":"Primary lateral sclerosis: Consensus diagnostic criteria","volume":"91","author":"Turner","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2024103011294285500_fcae288-B50","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: Neurofilament light chain levels in definite subtypes of disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol"},{"issue":"7","key":"2024103011294285500_fcae288-B51","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"2024103011294285500_fcae288-B52","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/biomedicines9111623","article-title":"CSF heavy neurofilament may discriminate and predict motor neuron diseases with upper motor neuron involvement","volume":"9","author":"Simonini","year":"2021","journal-title":"Biomedicines"},{"issue":"1\u20132","key":"2024103011294285500_fcae288-B53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/21678421.2021.1939384","article-title":"Cardiac troponin T is elevated and increases longitudinally in ALS patients","volume":"23","author":"Kl\u00e4ppe","year":"2022","journal-title":"Amyotroph Lateral Scler Front Degener"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcae288\/58919073\/fcae288.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/5\/fcae288\/59865932\/fcae288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/6\/5\/fcae288\/59865932\/fcae288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:46:18Z","timestamp":1730288778000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcae288\/7741173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcae288","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"fcae288"}}